YY1 and neoplasm: Studies have found that mTOR inhibitors can inhibit the growth of tumor regions rich in nutrients, but, in the central regions that rely on the YY1–FGD6 axis, the inhibitory function of mTOR inhibitors on cell growth is weakened [119].